A Brighter
Future for
Alzheimer’s is Within Reach
Today, Alzheimer's is a top 10 cause of death.
are living with Alzheimer's. By 2060, this number is projected to rise to 13.8 million. We all feel the impact. Without action, the U.S. will spend $1 trillion on treatments alone by 2050.
As a leader fighting for Americans with chronic disease, the Partnership to Fight Chronic Diseases (PFCD) advocates for improved access to treatments, a streamlined regulatory process, and policy reforms that ensure Americans with Alzheimer’s benefit from the latest scientific advances.
We have the tools to change the fate of early stages of Alzheimer's. We must deploy them urgently.
Recent progress in the fight against Alzheimer’s:
-
The FDA has approved new therapies and diagnostic tools for early-stage Alzheimer's, offering new hope to people with the disease.
-
Medicare hasn't kept up, so the disease marches on leaving seniors unable to access approved care in a timely and affordable way.
-
A broad coalition of stakeholders, policymakers, and community leaders urge Medicare to update their policies to reflect advancing science.
The future of Alzheimer’s care is bright…
-
We now know that markers of Alzheimer’s are present in the brain years before symptoms.
-
Research is showing great promise for much earlier intervention.
-
Blood-based tests show promise to detect the disease in these pre-symptom stages.
-
Ongoing research and clinical studies are exploring more to better understand risk factors, modifiable lifestyle changes and the potential for earlier treatment and interventions that could help people take action before the symptoms of the disease set in.
Decisionmakers in Washington can help…
Anticipate future scientific advances and urgently correct misaligned policies, including:
-
Remove the red tape and outdated policies that keep people with Alzheimer’s from getting treatments that could help.
-
Clear the path for Americans to access blood tests that make it much easier to detect and diagnose the disease.
